CAS NO. |
Products Name |
1620401-82-2 |
UNC-0379 |
more... |
UNC0379 is a selective, substrate-competitive inhibitor of the lysine methyltransferase SETD8 with IC50 of 7.3±1.0 uM; selective over 15 other methyltransferases. |
|
1429881-91-3 |
UNC2025 |
more... |
UNC2025 is a potent and orally bioavailable Mer/Flt3 dual inhibitor with IC50 of 0.8/0.74 nM for Mer/Flt3 |
|
|
940929-33-9 |
SB743921 |
more... |
SB-743921 is a second generation, highly potent and active KSP inhibitor with Ki of 0.1 nM; no affinity to MKLP1, Kin2, Kif1A, Kif15, KHC, Kif4 and CENP-E. |
|
1072833-77-2 |
MLN2238 |
more... |
MLN2238(Ixazomib) inhibits the chymotrypsin-like proteolytic (β5) site of the 20S proteasome with IC50 and Ki of 3.4 nM and 0.93 nM, respectively. |
|
1201902-80-8 |
MLN9708 |
more... |
MLN9708 immediately hydrolyzed to MLN2238, which is an N-capped dipeptidyl leucine boronic acid and preferentially bound to and inhibited the 20S proteasome with an IC50 value of 3.4 nM (Ki = 0.93 nM). |
|
336113-53-2 |
Ispinesib(SB-715992) |
more... |
Ispinesib is a potent, specific and reversible inhibitor of KSP (HsEg5) with Ki of 1.7 nM. Ispinesib is a synthetic small molecule, derived from quinazolinone, with antineoplastic properties. |
|
718630-59-2 |
PHA-793887 |
more... |
PHA-793887 is a novel and potent inhibitor of CDK2, CDK5 and CDK7 with IC50 of 8 nM, 5 nM and 10 nM. It is greater than 6-fold more selective for CDK2, 5, and 7 than CDK1, 4, and 9. Phase 1. |
|
|
1088965-37-0 |
GSK923295 |
more... |
GSK923295 is a first-in-class, specific allosteric inhibitor of CENP-E kinesin motor ATPase with Ki of 3.2 nM, and less potent to mutant I182 and T183. |
|
475488-23-4 |
NVP-ADW742 |
more... |
NVP-ADW742(ADW742; GSK 552602A ) is an selective IGF-1R inhibitor with IC50 of 0.17 μM, >16-fold more potent against IGF-1R than InsR; little activity to HER2, PDGFR, VEGFR-2, Bcr-Abl and c-Kit. |
|
354812-17-2 |
SC-514 |
more... |
SC-514 (GK 01140), a small molecule, is a selective inhibitor of IKK-2; does not inhibit other IKK isoforms or other serine-threonine and tyrosine kinases. |
|